NASDAQ:KTTA | Cash Flow Statement | Pasithea Therapeutics Corp.

Complete source-backed cash-flow history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$5.27M
2026-03-31-$2.87M-$4.79M$750.00
2025-12-31-$10.11M-$5.4M$56.42M
2025-09-30-$3.04M
2025-06-30-$3.72M
2025-03-31-$3.56M-$3.06M$1.47M
2024-12-31-$3.18M-$2.44M-$23,550.00
2024-09-30-$3M
2024-06-30-$3.87M
2024-03-31-$3.86M-$4.32M
2023-12-31-$5.05M-$3.29M-$36.00$0.00
2023-09-30-$3.61M
2023-06-30-$3.76M
2023-03-31-$3.54M-$3.2M$53,888.00$264,103.00
2022-12-31-$5.12M-$4.42M$92,725.00-$1.76M
2022-09-30-$4.59M
2022-06-30-$2.66M
2022-03-31-$1.57M-$2.53M$1,951.00-$113,867.00
2021-12-31$630,143.00-$1.74M$12,933.00-$12,933.00$34.17M
2021-09-30-$1.53M
2021-06-30-$727,947.00
2021-03-31-$549,609.00-$381,845.00$1.21M
2020-09-30-$13,970.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$20.43M-$15.21M$11,000.00$63.52M
2024-12-31-$13.9M-$13.92M$4.52M
2023-12-31-$15.96M-$12.81M$34,301.00$3.73M
2022-12-31-$13.94M-$14.56M$107,101.00-$2.06M-$3.21M
2021-12-31-$2.17M-$3.17M$21,503.00-$21,503.00$55.93M